Account
Inquiry
Tirzepatide 20mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications in metabolic disorders. This synthetic peptide analogue demonstrates significant potential in diabetes and obesity research studies.
As a GIP and GLP-1 receptor agonist, tirzepatide 20mg works through multiple mechanisms including enhanced insulin secretion, reduced glucagon secretion, slowed gastric emptying, and increased satiety. These combined effects make it particularly interesting for metabolic research applications.
Our tirzepatide 20mg is produced under strict quality control standards in GMP-certified facilities. The white lyophilized powder is carefully packaged to ensure stability and purity throughout transportation and storage. Each batch undergoes comprehensive analytical testing including HPLC, mass spectrometry, and amino acid analysis to verify identity and purity.
For research purposes only. Not for human consumption. Proper handling procedures should be followed when working with peptide compounds in laboratory settings.
